Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

579 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: a double-blind study as adjunctive therapy to levodopa.
Rabey JM, Sagi I, Huberman M, Melamed E, Korczyn A, Giladi N, Inzelberg R, Djaldetti R, Klein C, Berecz G; Rasagiline Study Group. Rabey JM, et al. Among authors: melamed e. Clin Neuropharmacol. 2000 Nov-Dec;23(6):324-30. doi: 10.1097/00002826-200011000-00005. Clin Neuropharmacol. 2000. PMID: 11575866 Clinical Trial.
High prevalence of malignant melanoma in Israeli patients with Parkinson's disease.
Inzelberg R, Rabey JM, Melamed E, Djaldetti R, Reches A, Badarny S, Hassin-Baer S, Cohen O, Trau H, Aharon-Peretz J, Milo R, Schwartz M, Huberman M, Gilead L, Barchana M, Liphshiz I, Fitzer-Attas C, Giladi N. Inzelberg R, et al. Among authors: melamed e. J Neural Transm (Vienna). 2011 Aug;118(8):1199-207. doi: 10.1007/s00702-011-0580-2. Epub 2011 Feb 5. J Neural Transm (Vienna). 2011. PMID: 21298300
Is there addiction to levodopa in patients with Parkinson's disease?
Merims D, Galili-Mosberg R, Melamed E. Merims D, et al. Among authors: melamed e. Mov Disord. 2000 Sep;15(5):1014-6. doi: 10.1002/1531-8257(200009)15:5<1014::aid-mds1041>3.0.co;2-o. Mov Disord. 2000. PMID: 11009217 No abstract available.
The natural history of multiple system atrophy: a prospective European cohort study.
Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Köllensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W; European Multiple System Atrophy Study Group. Wenning GK, et al. Among authors: melamed e. Lancet Neurol. 2013 Mar;12(3):264-74. doi: 10.1016/S1474-4422(12)70327-7. Epub 2013 Feb 5. Lancet Neurol. 2013. PMID: 23391524 Free PMC article.
579 results